Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (4)
Early P 1 (1)
P 1 (1)
P 2 (7)

Trial Status

Recruiting9
Completed7
Unknown6
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT03803787Phase 2RecruitingPrimary

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

NCT04676828Not ApplicableRecruiting

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

NCT07312682Active Not Recruiting

Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy

NCT07339644Not ApplicableRecruiting

Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study

NCT06557343RecruitingPrimary

Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy

NCT02735746Completed

Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis

NCT05365802Early Phase 1Recruiting

FAPI PET for Lung Fibrosis

NCT06861179Phase 1CompletedPrimary

The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis

NCT05189496Not ApplicableRecruitingPrimary

Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis

NCT06069115Recruiting

Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort

NCT06570317Recruiting

Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC

NCT06079931Phase 2UnknownPrimary

The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia

NCT03796364Phase 2CompletedPrimary

Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis

NCT04863027Completed

Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning.

NCT02490319UnknownPrimary

Study on the Biological Prediction Models of Radiation Pneumonitis

NCT05448703RecruitingPrimary

A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis

NCT04632342Phase 2UnknownPrimary

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

NCT01754909Phase 2Completed

Mitigation of Radiation Pneumonitis and Fibrosis

NCT01745484Not ApplicableCompleted

Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation

NCT03462524Completed

Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

Scroll to load more

Research Network

Activity Timeline